CD274 and lung cancer: In order to explore the limitations of conventional [18F]-FDG-PET scans for accurately assessing the response to immunotherapy treatments, we used a lung cancer syngeneic mouse model exposed to PD-1/PD-L1 axis blockade, as previously published (16).